supp.fit

Magnesium, Vitamin D and Zinc: study protocols

9 study groups took Magnesium together with Vitamin D and Zinc. These are the doses the studies gave. They are not a recommendation.

Magnesium: what the research found →

Dose per serving from research: Magnesium

9 study groups in 8 studies say how much Magnesium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mg to 100 mg, 44% of 9 study groups.

Daily doseStudy groups
50 mg to 100 mg
4
100 mg to 250 mg
3
250 mg to 500 mg
1
over 500 mg
1

Dose per serving from research: Vitamin D

5 study groups in 4 studies say how much Vitamin D participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mcg to 25 mcg, 80% of 5 study groups.

Daily doseStudy groups
5 mcg or less
1
5 mcg to 10 mcg
0
10 mcg to 25 mcg
4

Dose per serving from research: Zinc

9 study groups in 8 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg, 44% of 9 study groups.

Daily doseStudy groups
1 mg to 2.5 mg
3
2.5 mg to 5 mg
1
5 mg to 10 mg
4
10 mg to 25 mg
1

Commonly used together

9 of 9 study groups took Magnesium, Vitamin D and Zinc with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Calcium
7

9 study groups

Study
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment
600 mg5 mcg5 mg90 days63
Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
2018 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS); age not reported
200 mg400 IU8 mg12 weeks30
Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
2022 · Treatment group · Children aged 6–17 years with obesity (BMI above the 95th percentile for age)
300 mg25 mcg7 mg26 weeks16
[Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial]
2004 · Group 1: Vitrum Osteomag · Postmenopausal women with osteopenia; age range not reported
80 mg400 IU15 mg1 year125
Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year
2018 · intervention · Chinese postmenopausal women in Malaysia; mean age 59 years
96 mg15 mcg2.4 mg1 year61
A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome
2017 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS)
200 mg400 IU8 mg12 weeks30
The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes
2019 · Magnesium-zinc-calcium-vitamin D group · Women aged 18–40 with gestational diabetes mellitus, at 24–28 weeks’ gestation at diagnosis
200 mg400 IU8 mg6 weeks30
Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women
2016 · Intervention (Int), premenopausal women · Premenopausal women, mean age 41 years; no specific condition stated
96 mg15 mcg2.4 mg12 weeks—
Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women
2016 · Intervention (Int), postmenopausal women · Postmenopausal women, mean age 59 years; no specific condition stated
96 mg15 mcg2.4 mg12 weeks—
Magnesium, Vitamin D and Zinc: study protocols | supp.fit